Gene therapy competitive dynamics: Winner takes all?
This article was originally published in Cell & Gene. It has also been published in Cell & Gene‘s sister publication, OutSourced Pharama. With many gene...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
For 25 years, our global team of senior experts has helped Life Science firms anticipate trends and break through strategic barriers. CRA’s fit-for-purpose designs go beyond a single project, to build a true strategic partnership, providing cross-functional support across industry stakeholders and geographies. Clients rely on CRA’s institutional knowledge and subject matter expertise to provide an independent perspective to address core business issues, drive change, and align internal stakeholders.
We help clients address challenges in four key areas of strategy.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comThis article was originally published in Cell & Gene. It has also been published in Cell & Gene‘s sister publication, OutSourced Pharama. With many gene...
Newborn screening (NBS), or the process of identifying members of a population who may have, or may be at risk of developing, a specific disease or condition,...
Griff Vinton presents his co-authored paper titled “Building a Machine Learning Model to Find Undiagnosed Patients in Rare Disease.” For more information on...
In this European Parliament expert briefing session supported by EUCOPE and Novartis Gene Therapies, Tim Wilsdon presents work CRA has conducted on behalf of...